ETSF for Latinx Young Adults with Alcohol Use Disorder
Culturally Adapting Spiritually and Technologically Informed Interventions to Reduce Alcohol-Related Health Disparities Among Latinx Young Adults- Aim 3 RCT
2 other identifiers
interventional
40
0 countries
N/A
Brief Summary
The goal of this clinical trial is to learn if the eTSF intervention is feasible among Latinx young adults with alcohol use disorder. The main questions it aims to answer are:
- Is eTSF feasible?
- Is eTSF effective in reducing alcohol use and increasing 12-step engagement compared to the control condition? The control condition will receive educational materials on drinking problems and a list of local/online AA meetings Participants will
- Be randomly assigned to either the eTSF condition or the control condition.
- Fill out the baseline online survey.
- Go through the eTSF app/control materials.
- And at 3 months post-baseline, fill out the follow-up online survey.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2027
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 26, 2024
CompletedFirst Posted
Study publicly available on registry
December 9, 2024
CompletedStudy Start
First participant enrolled
January 1, 2027
ExpectedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2028
Study Completion
Last participant's last visit for all outcomes
February 1, 2029
December 9, 2024
December 1, 2024
1.9 years
November 26, 2024
December 4, 2024
Conditions
Outcome Measures
Primary Outcomes (9)
Recruitment feasibility
Recruitment feasibility will be measured by the number of participants screened and enrolled each month.
Every 4 weeks up to 2 years
Randomization feasibility
Randomization feasibility will be measured by the number of baseline demographic variables with statistically significant group differences.
From recruitment to baseline assessment up to two years
Retention/attrition feasibility
Retention/attrition feasibility will be measured by retention rates in each condition.
From recruitment to the end of the trial at three months.
Adherence feasibility
Adherence feasibility will be measured by the percentage of eTSF app components used by the eTSF condition participants.
From recruitment to the end of the trial at three months.
Assessment feasibility
Assessment feasibility will be measured by the proportion of missing data in each assessment.
From recruitment to the end of the trial at three months.
Intervention credibility
Intervention credibility will be measured using a single-item question: "On a scale from 1 to 5, where 1 indicates 'not at all' and 5 indicates 'very much,' to what extent do you believe this treatment will be beneficial for you?" Only eTSF condition participants will receive this measure.
From baseline to the end of treatment at three months.
Intervention satisfaction
Intervention satisfaction will be measured using the mHealth Satisfaction Questionnaire, which has a total score range from 14 to 42. Higher total scores indicate greater user satisfaction with the mHealth app.
From baseline to the end of treatment at three months.
Intervention acceptability
Acceptability will be measured using the Abbreviated Acceptability Rating Profile, which scores range from 8 to 48. Higher scores indicate greater acceptability of the intervention.
From baseline to the end of treatment at three months.
Intervention engagement
Intervention engagement will be automatically recorded by the app during the study period and be measured in terms of app opening frequency, time spent on the app per use session (i.e., the time between opening and closing the app), most frequently used intervention component, time spent per intervention component, the completion rate of each selected component, reports of technical problems.
From baseline to the end of treatment at three months.
Secondary Outcomes (2)
Alcohol use
From baseline to the end of treatment at three months.
12-Step fellowship engagement
From baseline to the end of treatment at three months.
Other Outcomes (3)
Drinking consequences
From baseline to the end of treatment at three months.
Drug use
From baseline to the end of treatment at three months.
Psychological distress
From baseline to the end of treatment at three months.
Study Arms (2)
eTSF
EXPERIMENTALThis arm will receive the eTSF intervention. eTSF is a smartphone app intervention featuring culturally relevant content aimed at supporting Latinx young adults with alcohol use disorder in participating in 12-step groups.
Educational control
ACTIVE COMPARATORThis arm will receive educational materials on drinking problems and a list of local/online AA meetings
Interventions
eTSF is a smartphone app intervention featuring culturally relevant content aimed at supporting Latinx young adults with alcohol use disorder in participating in 12-step groups.
Educational materials on drinking problems and a list of local/online AA meetings.
Eligibility Criteria
You may qualify if:
- YAs age 18-29
- Identify as Latinx
- Meet the Diagnostic \& Statistical Manual of Mental Disorders 5th edition (DSM-5) diagnostic criteria for alcohol use disorder
- Are at least minimally motivated to change their drinking (i.e., scoring ≥3 on the University of Rhode Island Change Assessment Scale's contemplation, action, or maintenance subscales and ≤3 on the precontemplation subscale)
- Be able to provide at least one contact person to assist in tracking them for follow-up assessment
You may not qualify if:
- Attending any 12-step program (≥2 meetings in the past month)
- Experiencing psychotic symptoms or cognitive impairment
- In alcohol or drug treatment programs
- Taking addiction treatment medications
- Experiencing, expecting to experience, or had a history of severe/complicated withdrawal
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
November 26, 2024
First Posted
December 9, 2024
Study Start (Estimated)
January 1, 2027
Primary Completion (Estimated)
December 1, 2028
Study Completion (Estimated)
February 1, 2029
Last Updated
December 9, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will share
The IPD will be shared on the NIAAA Data Archive.